⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

GRANULES - IntraDay Trade Analysis with Live Signals

← Back to List

⭐ Rating: 2.5

Last Updated Time : 19 Sept 26, 10:07 am

Key Parameters

⭐ IntraDay Trade Rating: 2.5

RSI53.8
MACD7.56
Volume12,30,165
Avg Vol 1Wk18,00,805
Low price511 ₹
High price924 ₹
Current Price875 ₹
DMA 50847 ₹
Show all parameters (20 more)
Stock CodeGRANULES
Market Cap23,878 Cr.
High / Low924 ₹
Stock P/E59.3
Book Value178 ₹
Dividend Yield0.20 %
ROCE12.8 %
ROE10.5 %
Face Value1.00 ₹
DMA 200733 ₹
Chg in FII Hold2.19 %
Chg in DII Hold-0.90 %
PAT Qtr71.8 Cr.
PAT Prev Qtr99.0 Cr.
PEG Ratio-9.26
Debt to equity0.19
52w Index88.2 %
Qtr Profit Var-8.70 %
EPS16.5 ₹
Industry PE34.8

🧾 Trade Setup

Buy Price: 870 ₹ – targeting a quick breakout given current momentum. Initial Stop Loss: 865 ₹ - protecting against immediate reversal of volume momentum. Profit Target 1: 885 ₹ – predicated on maintaining the upward trend, aiming for a 3% gain. Profit Target 2: 895 ₹ – contingent upon sustained high volume and a breach of the previous high of 924 ₹. Overall verdict: High-risk, short-term trade capitalizing on current momentum amidst promoter selling risk; prioritize tight stop loss management.

✅ Positive

The stock is seeing a significant volume spike today – 12.3M shares traded, substantially higher than the average weekly volume of 18M. The MACD indicator shows a positive slope, suggesting continued upward momentum.

⚠️ Limitation

The P/E ratio of 59.3 is significantly elevated compared to the industry PE of 34.8, indicating overvaluation. Furthermore, the recent news highlights a large promoter sale, introducing immediate selling pressure that could quickly reverse gains.

📉 Company Negative News

Promoter selling has eroded group stake to 31.08% and raises concerns about long-term confidence in management's strategy. Granules India turns debt-free in Q1FY27, sets peptide CDMO targets – scanx.trade indicates targets set are more of a future outlook than immediate support for the stock price today.

🏭 Industry

The pharmaceutical sector remains generally strong due to ongoing demand for generic drugs and increasing healthcare expenditure globally, although recent concerns about drug pricing pressures create volatility.

Choose Technical Analysis or Fundamental Analysis above to load it.

How GRANULES Rates Across All Strategies

★ 2.5
Entry Price: 870 ₹.
Intraday
★ 2.5
You're viewing this analysis below.
★ 2.5
An entry price zone between 820 ₹ and 850 ₹ offers a reasonable oppor…
★ 2.5
Optimal entry zones would be around the 875 ₹ current price – a short…
★ 2.8
We recommend a cautious entry zone between ₹850 - ₹890, acknowledging…

NIFTY 50 · Intraday Trading

NEXT 50 · Intraday Trading

MIDCAP · Intraday Trading

SMALLCAP · Intraday Trading